Empirically Reduced Dosages of Tinzaparin in Patients with Moderate-to-Severe Renal Insufficiency Lead to Inadequate Anti-Xa Levels

Renske H. Olie*, Nathalie E. L. Meertens, Yvonne M. C. Henskens, Hugo ten Cate

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)113-123
Number of pages11
JournalThe Nephron Journals
Volume137
Issue number2
DOIs
Publication statusPublished - Oct 2017

Keywords

  • Low molecular weight heparin
  • Anti-Xa activity
  • Anticoagulation therapy
  • Renal insufficiency
  • Dosage adjustment
  • MOLECULAR-WEIGHT HEPARIN
  • ELDERLY-PATIENTS
  • HEALTHY-VOLUNTEERS
  • PHARMACODYNAMICS
  • ENOXAPARIN
  • THERAPY
  • ACCUMULATION
  • IMPAIRMENT
  • NADROPARIN
  • DISEASE

Cite this